News | May 19, 2014

GE Healthcare, CorTechs Labs to Co-Market NeuroQuant for Quantifying Brain Volume Loss

May 19, 2014 — GE Healthcare and CorTechs Labs announced the signing of a strategic joint-marketing agreement at the joint meeting of the International Society of Magnetic Resonance in Medicine (ISMRM) and the European Society of Magnetic Resonance in Medicine and Biology (ESMRMB), held in Milan. The companies will collaborate to co-market an MRI (magnetic resonance imaging) scanning solution combined with NeuroQuant, CorTechs Labs’ MRI post-processing application.

NeuroQuant enables the acquisition of volumetric brain image data and automatically conducts accurate and consistent measurements of cortical and subcortical volumes targeted at identifying evidence of neurodegeneration. This innovative solution will provide neurologists and radiologists with objective support for their clinical impression.

“Accurate measurement of volumes of different parts of the brain may be a useful aid in the diagnosis of neurodegenerative diseases such as Alzheimer’s, multiple sclerosis and traumatic brain injury," said Chris Airriess, chief technology officer, CorTechs Labs. "Volume changes in certain brain structures have been linked in the literature to early indications of such conditions where more traditional diagnoses lack detection sensitivity.”

NeuroQuant does this in an automated fashion, without user intervention, and is the only U.S. Food and Drug Administration (FDA) 510(k) approved software for this application.

“CorTechs Labs is a pioneer and a trendsetter in the area of software for the aid of brain diagnostics and is widely used in clinical practices worldwide,” said Baldev Ahluwalia, premium segment manager at GE Healthcare, MRI. “We at GE Healthcare look forward to collaborating with CorTech Labs, benefitting from their innovative approach to providing the highly desired quantitative brain volumetric information with NeuroQuant.”

"We're pleased to expand our relationship with GE Healthcare,” said Guri Stark, CEO of CorTechs Labs. “We look forward to working with GE Healthcare to empower clinicians with objective quantitative data, while continuing NeuroQuant’s growth momentum. In turn, this furthers our vision to establish NeuroQuant as the standard measurement solution for all brain disorders, including Alzheimer’s disease, epilepsy, multiple sclerosis and traumatic brain injury."

For more information: www.cortechslabs.com, www.gehealthcare.com

Related Content

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI) | January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Smartphone Addiction Creates Imbalance in Brain
News | Mobile Devices | January 11, 2018
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet,...
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Weight Loss Through Exercise Alone Does Not Protect Knees
News | Orthopedic Imaging | January 11, 2018
January 11, 2018 – Obese people who lose a substantial amount of weight can significantly slow down the degeneration
Neurofeedback Shows Promise in Treating Tinnitus

The standard approach to fMRI neurofeedback. Image courtesy of Matthew Sherwood, Ph.D.

News | Magnetic Resonance Imaging (MRI) | January 11, 2018
January 11, 2018 — Researchers using...
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
State-of-the-Art MRI Technology Bypasses Need for Biopsy
News | Magnetic Resonance Imaging (MRI) | January 09, 2018
January 9, 2018 – The most common type of tumor found in the kidney is generally quite small (less than 1.5 in).
New Studies Show Brain Impact of Youth Football
News | Neuro Imaging | January 09, 2018
School-age football players with a history of concussion and high impact exposure undergo brain changes after one...
Overlay Init